Skip to content
6-K

Foreign Interim / Material

VectivBio Holding AG

0001193125-22-261824

← back to feed
Filed
Oct 13, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2022 · Jun 30, 2022 35.56M sh
Shares Diluted Q2 2022 · Jun 30, 2021 19.98M sh
Operating Cash Flow Q2 2022 · Jun 30, 2022 −$9.76M
Operating Cash Flow Q2 2022 · Jun 30, 2021 −$36.98M
Cash And Equivalents Q2 2022 · Jun 30, 2022 $142.14M
Cash And Equivalents Q2 2022 · Dec 31, 2021 $102.71M
Cash And Equivalents Q2 2022 · Jun 30, 2021 $144.61M
Cash And Equivalents Q2 2022 · Dec 31, 2020 $40.17M
Stockholders Equity Q2 2022 · Jun 30, 2022 $141.83M
Stockholders Equity Q2 2022 · Dec 31, 2021 $116M
Stockholders Equity Q2 2022 · Jun 30, 2021 $140.4M
Stockholders Equity Q2 2022 · Dec 31, 2020 $32.24M
Current Liabilities Q2 2022 · Jun 30, 2022 $32.54M
Current Liabilities Q2 2022 · Dec 31, 2021 $17.18M
Total Liabilities Q2 2022 · Jun 30, 2022 $36.19M
Total Liabilities Q2 2022 · Dec 31, 2021 $20.53M
Current Assets Q2 2022 · Jun 30, 2022 $152.45M
Current Assets Q2 2022 · Dec 31, 2021 $110.08M
Total Assets Q2 2022 · Jun 30, 2022 $178.01M
Total Assets Q2 2022 · Dec 31, 2021 $136.53M
Eps Diluted Q2 2022 · Jun 30, 2022 −$0.86
Eps Diluted Q2 2022 · Jun 30, 2021 −$2.26
Eps Basic Q2 2022 · Jun 30, 2022 −$0.86
Eps Basic Q2 2022 · Jun 30, 2021 −$2.26
Rd Expense Q2 2022 · Jun 30, 2022 $37.51M
Rd Expense Q2 2022 · Jun 30, 2021 $26.49M
Operating Income Q2 2022 · Jun 30, 2022 −$30.92M
Operating Income Q2 2022 · Jun 30, 2021 −$45.59M